Select Medical Holdings (SEM) Depreciation & Amortization (CF) (2018 - 2026)

Select Medical Holdings has disclosed Depreciation & Amortization (CF) across 9 years of filings, most recently posting $37.7 million for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) rose 8.21% year-over-year to $37.7 million; the TTM figure through Mar 2026 stood at $143.2 million (down 22.46% YoY), while the FY2025 annual figure was $140.3 million, down 31.19% from the prior year.
• Depreciation & Amortization (CF) improved to $37.7 million in Q1 2026, from $36.2 million in the prior quarter.
• Over the last five years, Depreciation & Amortization (CF) for SEM reached as high as $54.1 million in Q1 2024 and fell as low as $34.4 million in Q3 2025.
• The 5-year median for Depreciation & Amortization (CF) is $51.0 million (2022), against an average of $46.8 million.
• Annual changes were most pronounced in 2025 — Depreciation & Amortization (CF) plunged 35.62% — and 2026, when it advanced 8.21%.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $52.2 million in 2022, then gained by 3.33% to $54.0 million in 2023, then slipped by 15.27% to $45.7 million in 2024, then dropped by 20.85% to $36.2 million in 2025, then rose by 4.04% to $37.7 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $37.7 million, $36.2 million, and $34.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.